{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:48:59Z","timestamp":1788522539095,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,14]]},"DOI":"10.7759\/cureus.108847","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:32:43Z","timestamp":1778772763000},"source":"Crossref","is-referenced-by-count":1,"title":["Primary Bile Acid Diarrhea: A Narrative Review of Pathophysiology, Diagnostic Challenges, and Emerging Therapeutic Strategies"],"prefix":"10.7759","author":[{"given":"Ayisha","family":"Maqsood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syeda Kashaf","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia Mohosina","family":"Moni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majd","family":"Aldin Oudeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ghaith","family":"Hulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rameeqa","family":"Ejaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa","family":"Abdelfattah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana Muhammad","family":"Naveed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Muhammad Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2024.12.019","article-title":"Bile acid diarrhea in patients with chronic diarrhea. Current appraisal and recommendations for clinical practice","volume":"57","author":"Barbara G","year":"2025","unstructured":"Barbara G, Bellini M, Portincasa P, et al.. Bile acid diarrhea in patients with chronic diarrhea. Current appraisal and recommendations for clinical practice. Dig Liver Dis. 2025, 57:680-7. 10.1016\/j.dld.2024.12.019","journal-title":"Dig Liver Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S93698","article-title":"Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome","volume":"9","author":"Lacy BE","year":"2016","unstructured":"Lacy BE. Diagnosis and treatment of diarrhea-predominant irritable bowel syndrome. Int J Gen Med. 2016, 9:7-17. 10.2147\/IJGM.S93698","journal-title":"Int J Gen Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldp032","article-title":"Recent advances in the understanding of bile acid malabsorption","volume":"92","author":"Pattni S","year":"2009","unstructured":"Pattni S, Walters JR. Recent advances in the understanding of bile acid malabsorption. Br Med Bull. 2009, 92:79-93. 10.1093\/bmb\/ldp032","journal-title":"Br Med Bull"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/apt.17739","article-title":"Prospective comparison of diagnostic tests for bile acid diarrhoea","volume":"59","author":"Borup C","year":"2024","unstructured":"Borup C, Vinter-Jensen L, J\u00f8rgensen SP, et al.. Prospective comparison of diagnostic tests for bile acid diarrhoea. Aliment Pharmacol Ther. 2024, 59:39-50. 10.1111\/apt.17739","journal-title":"Aliment Pharmacol Ther"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13767","article-title":"Targeting the FGF19-FGFR4 pathway for cholestatic, metabolic, and cancerous diseases","volume":"295","author":"Li X","year":"2024","unstructured":"Li X, Lu W, Kharitonenkov A, Luo Y. Targeting the FGF19-FGFR4 pathway for cholestatic, metabolic, and cancerous diseases. J Intern Med. 2024, 295:292-312. 10.1111\/joim.13767","journal-title":"J Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00095","article-title":"Dissecting the role of the FGF19-FGFR4 signaling pathway in cancer development and progression","volume":"8","author":"Liu Y","year":"2020","unstructured":"Liu Y, Cao M, Cai Y, Li X, Zhao C, Cui R. Dissecting the role of the FGF19-FGFR4 signaling pathway in cancer development and progression. Front Cell Dev Biol. 2020, 8:95. 10.3389\/fcell.2020.00095","journal-title":"Front Cell Dev Biol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04081.x","article-title":"Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome","volume":"30","author":"Wedlake L","year":"2009","unstructured":"Wedlake L, A'Hern R, Russell D, Thomas K, Walters JR, Andreyev HJ. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2009, 30:707-17. 10.1111\/j.1365-2036.2009.04081.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/2050640614527938","article-title":"Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals","volume":"2","author":"Renner O","year":"2014","unstructured":"Renner O, Harsch S, Matysik S, L\u00fctjohann D, Schmitz G, Stange EF. Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals. United European Gastroenterol J. 2014, 2:216-25. 10.1177\/2050640614527938","journal-title":"United European Gastroenterol J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2020-101436","article-title":"Bile acid diarrhoea: pathophysiology, diagnosis and management","volume":"12","author":"Farrugia A","year":"2021","unstructured":"Farrugia A, Arasaradnam R. Bile acid diarrhoea: pathophysiology, diagnosis and management. Frontline Gastroenterol. 2021, 12:500-7. 10.1136\/flgastro-2020-101436","journal-title":"Frontline Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00060","article-title":"Attenuation of the hepatoprotective effects of ileal apical sodium dependent bile acid transporter (ASBT) inhibition in choline-deficient L-amino acid-defined (CDAA) diet-fed mice","volume":"7","author":"Rao A","year":"2020","unstructured":"Rao A, van de Peppel IP, Gumber S, Karpen SJ, Dawson PA. Attenuation of the hepatoprotective effects of ileal apical sodium dependent bile acid transporter (ASBT) inhibition in choline-deficient L-amino acid-defined (CDAA) diet-fed mice. Front Med (Lausanne). 2020, 7:60. 10.3389\/fmed.2020.00060","journal-title":"Front Med (Lausanne)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305965","article-title":"Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS","volume":"64","author":"Bajor A","year":"2015","unstructured":"Bajor A, T\u00f6rnblom H, Rudling M, Ung KA, Simr\u00e9n M. Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS. Gut. 2015, 64:84-92. 10.1136\/gutjnl-2013-305965","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13227","article-title":"Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea","volume":"42","author":"Slattery SA","year":"2015","unstructured":"Slattery SA, Niaz O, Aziz Q, Ford AC, Farmer AD. Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment Pharmacol Ther. 2015, 42:3-11. 10.1111\/apt.13227","journal-title":"Aliment Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.215","article-title":"Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea","volume":"109","author":"Camilleri M","year":"2014","unstructured":"Camilleri M, Busciglio I, Acosta A, et al.. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea. Am J Gastroenterol. 2014, 109:1621-30. 10.1038\/ajg.2014.215","journal-title":"Am J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00436-8","article-title":"Lessons from a trial of colesevelam for bile acid diarrhoea","volume":"8","author":"Walters JR","year":"2023","unstructured":"Walters JR. Lessons from a trial of colesevelam for bile acid diarrhoea. Lancet Gastroenterol Hepatol. 2023, 8:290-1. 10.1016\/S2468-1253(22)00436-8","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02224-z","article-title":"A narrative review of irritable bowel syndrome with diarrhea: a primer for primary care providers","volume":"39","author":"Moshiree B","year":"2022","unstructured":"Moshiree B, Heidelbaugh JJ, Sayuk GS. A narrative review of irritable bowel syndrome with diarrhea: a primer for primary care providers. Adv Ther. 2022, 39:4003-20. 10.1007\/s12325-022-02224-z","journal-title":"Adv Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.04.029","article-title":"Methods for diagnosis of bile acid malabsorption in clinical practice","volume":"11","author":"Vijayvargiya P","year":"2013","unstructured":"Vijayvargiya P, Camilleri M, Shin A, Saenger A. Methods for diagnosis of bile acid malabsorption in clinical practice. Clin Gastroenterol Hepatol. 2013, 11:1232-9. 10.1016\/j.cgh.2013.04.029","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2097359","article-title":"Pros and cons of the SeHCAT test in bile acid diarrhea: a more appropriate use of an old nuclear medicine technique","volume":"2018","author":"Fani B","year":"2018","unstructured":"Fani B, Bertani L, Paglianiti I, et al.. Pros and cons of the SeHCAT test in bile acid diarrhea: a more appropriate use of an old nuclear medicine technique. Gastroenterol Res Pract. 2018, 2018:2097359. 10.1155\/2018\/2097359","journal-title":"Gastroenterol Res Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11113102","article-title":"Pathophysiology and clinical management of bile acid diarrhea","volume":"11","author":"Marasco G","year":"2022","unstructured":"Marasco G, Cremon C, Barbaro MR, et al.. Pathophysiology and clinical management of bile acid diarrhea. J Clin Med. 2022, 11:3102. 10.3390\/jcm11113102","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21037\/tgh-23-96","article-title":"Management of irritable bowel syndrome: a narrative review","volume":"9","author":"Tetali B","year":"2024","unstructured":"Tetali B, Suresh S. Management of irritable bowel syndrome: a narrative review. Transl Gastroenterol Hepatol. 2024, 9:26. 10.21037\/tgh-23-96","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327737","article-title":"British Society of Gastroenterology guidelines on the management of functional dyspepsia","volume":"71","author":"Black CJ","year":"2022","unstructured":"Black CJ, Paine PA, Agrawal A, et al.. British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut. 2022, 71:1697-723. 10.1136\/gutjnl-2022-327737","journal-title":"Gut"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13570","article-title":"Review article: bile acid diarrhoea - pathogenesis, diagnosis and management","volume":"43","author":"Mottacki N","year":"2016","unstructured":"Mottacki N, Simr\u00e9n M, Bajor A. Review article: bile acid diarrhoea - pathogenesis, diagnosis and management. Aliment Pharmacol Ther. 2016, 43:884-98. 10.1111\/apt.13570","journal-title":"Aliment Pharmacol Ther"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031544","article-title":"Bile acid diarrhea: from molecular mechanisms to clinical diagnosis and treatment in the era of precision medicine","volume":"25","author":"Yang D","year":"2024","unstructured":"Yang D, Lyu C, He K, Pang K, Guo Z, Wu D. Bile acid diarrhea: from molecular mechanisms to clinical diagnosis and treatment in the era of precision medicine. Int J Mol Sci. 2024, 25:1544. 10.3390\/ijms25031544","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12684","article-title":"Systematic review: the management of chronic diarrhoea due to bile acid malabsorption","volume":"39","author":"Wilcox C","year":"2014","unstructured":"Wilcox C, Turner J, Green J. Systematic review: the management of chronic diarrhoea due to bile acid malabsorption. Aliment Pharmacol Ther. 2014, 39:923-39. 10.1111\/apt.12684","journal-title":"Aliment Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2017-100826","article-title":"A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhoea","volume":"8","author":"Turner JM","year":"2017","unstructured":"Turner JM, Pattni SS, Appleby RN, Walters JR. A positive SeHCAT test results in fewer subsequent investigations in patients with chronic diarrhoea. Frontline Gastroenterol. 2017, 8:279-83. 10.1136\/flgastro-2017-100826","journal-title":"Frontline Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14214","article-title":"Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea","volume":"46","author":"Vijayvargiya P","year":"2017","unstructured":"Vijayvargiya P, Camilleri M, Carlson P, et al.. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea. Aliment Pharmacol Ther. 2017, 46:581-8. 10.1111\/apt.14214","journal-title":"Aliment Pharmacol Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/1756283X10377126","article-title":"Managing bile acid diarrhoea","volume":"3","author":"Walters JR","year":"2010","unstructured":"Walters JR, Pattni SS. Managing bile acid diarrhoea. Ther Adv Gastroenterol. 2010, 3:349-57. 10.1177\/1756283X10377126","journal-title":"Ther Adv Gastroenterol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-food-041715-033159","article-title":"Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health","volume":"7","author":"Joyce SA","year":"2016","unstructured":"Joyce SA, Gahan CG. Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health. Annu Rev Food Sci Technol. 2016, 7:313-33. 10.1146\/annurev-food-041715-033159","journal-title":"Annu Rev Food Sci Technol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.07.029","article-title":"The FXR-FGF19 gut-liver axis as a novel \"hepatostat\"","volume":"149","author":"Avila MA","year":"2015","unstructured":"Avila MA, Moschetta A. The FXR-FGF19 gut-liver axis as a novel \"hepatostat\". Gastroenterology. 2015, 149:537-40. 10.1053\/j.gastro.2015.07.029","journal-title":"Gastroenterology"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309889","article-title":"Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis","volume":"65","author":"Valentin N","year":"2016","unstructured":"Valentin N, Camilleri M, Altayar O, Vijayvargiya P, Acosta A, Nelson AD, Murad MH. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis. Gut. 2016, 65:1951-9. 10.1136\/gutjnl-2015-309889","journal-title":"Gut"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-019-1102-1","article-title":"Methods for diagnosing bile acid malabsorption: a systematic review","volume":"19","author":"Lyutakov I","year":"2019","unstructured":"Lyutakov I, Ursini F, Penchev P, Caio G, Carroccio A, Volta U, De Giorgio R. Methods for diagnosing bile acid malabsorption: a systematic review. BMC Gastroenterol. 2019, 19:185. 10.1186\/s12876-019-1102-1","journal-title":"BMC Gastroenterol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.5009\/gnl14397","article-title":"Bile Acid diarrhea: prevalence, pathogenesis, and therapy","volume":"9","author":"Camilleri M","year":"2015","unstructured":"Camilleri M. Bile Acid diarrhea: prevalence, pathogenesis, and therapy. Gut Liver. 2015, 9:332-9. 10.5009\/gnl14397","journal-title":"Gut Liver"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3399\/BJGP.2025.0613","article-title":"Bile acid diarrhoea: a clinical conundrum in primary care","volume":"76","author":"Thirkettle J","year":"2026","unstructured":"Thirkettle J, McLaughlin J, Raza M. Bile acid diarrhoea: a clinical conundrum in primary care. Br J Gen Pract. 2026, 76:45-7. 10.3399\/BJGP.2025.0613","journal-title":"Br J Gen Pract"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000863","article-title":"Bile acid diarrhea is associated with an increased risk of type 2 diabetes and cardiovascular disease: a nationwide cohort study","volume":"16","author":"Ellegaard AM","year":"2025","unstructured":"Ellegaard AM, Winther-Jensen M, K\u00e5rhus LL, Knop FK, K\u00e5rhus ML. Bile acid diarrhea is associated with an increased risk of type 2 diabetes and cardiovascular disease: a nationwide cohort study. Clin Transl Gastroenterol. 2025, 16:e00863. 10.14309\/ctg.0000000000000863","journal-title":"Clin Transl Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/471093-primary-bile-acid-diarrhea-a-narrative-review-of-pathophysiology-diagnostic-challenges-and-emerging-therapeutic-strategies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:32:43Z","timestamp":1778772763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/471093-primary-bile-acid-diarrhea-a-narrative-review-of-pathophysiology-diagnostic-challenges-and-emerging-therapeutic-strategies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.108847","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,14]]}}}